Fibrocell Science (NASDAQ:FCSC) is scheduled to be announcing its earnings results before the market opens on Monday, March 19th. Analysts expect the company to announce earnings of ($0.23) per share for the quarter.
Shares of Fibrocell Science (NASDAQ:FCSC) traded up $0.03 on Tuesday, hitting $0.64. The stock had a trading volume of 97,167 shares, compared to its average volume of 687,312. The firm has a market cap of $15.07, a P/E ratio of -0.35 and a beta of 0.51. Fibrocell Science has a 12 month low of $0.51 and a 12 month high of $4.64.
Several analysts have recently commented on FCSC shares. Zacks Investment Research upgraded Fibrocell Science from a “hold” rating to a “buy” rating and set a $0.75 target price for the company in a research note on Tuesday, March 6th. HC Wainwright set a $6.00 target price on Fibrocell Science and gave the company a “buy” rating in a research note on Tuesday, January 30th.
ILLEGAL ACTIVITY WARNING: “Fibrocell Science (FCSC) Set to Announce Quarterly Earnings on Monday” was published by Ticker Report and is owned by of Ticker Report. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.tickerreport.com/banking-finance/3259314/fibrocell-science-fcsc-set-to-announce-quarterly-earnings-on-monday.html.
Fibrocell Science, Inc is an autologous cell and gene therapy company. The Company is focused on discovering and developing localized therapies for diseases affecting the skin, connective tissue and joints. Its product candidate, azficel-T, is in development to treat patients suffering from vocal cord scarring that is either idiopathic or age-related.
Receive News & Ratings for Fibrocell Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fibrocell Science and related companies with MarketBeat.com's FREE daily email newsletter.